- Home
- SNX vs NBIX Comparison
SNX vs NBIX Comparison
Compare SNX & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNX
- NBIX
- Stock Information
- Founded
- SNX 1980
- NBIX 1992
- Country
- SNX United States
- NBIX United States
- Employees
- SNX N/A
- NBIX N/A
- Industry
- SNX Retail: Computer Software & Peripheral Equipment
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNX Technology
- NBIX Health Care
- Exchange
- SNX Nasdaq
- NBIX Nasdaq
- Market Cap
- SNX 11.7B
- NBIX 13.2B
- IPO Year
- SNX 2003
- NBIX 1996
- Fundamental
- Price
- SNX $151.64
- NBIX $141.87
- Analyst Decision
- SNX Strong Buy
- NBIX Strong Buy
- Analyst Count
- SNX 10
- NBIX 18
- Target Price
- SNX $149.80
- NBIX $161.50
- AVG Volume (30 Days)
- SNX 550.0K
- NBIX 726.3K
- Earning Date
- SNX 09-25-2025
- NBIX 10-29-2025
- Dividend Yield
- SNX 1.16%
- NBIX N/A
- EPS Growth
- SNX 19.95
- NBIX 2.97
- EPS
- SNX 8.55
- NBIX 3.39
- Revenue
- SNX $60,007,297,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- SNX $4.71
- NBIX $20.66
- Revenue Next Year
- SNX $4.14
- NBIX $14.64
- P/E Ratio
- SNX $17.73
- NBIX $41.84
- Revenue Growth
- SNX 6.60
- NBIX 18.42
- 52 Week Low
- SNX $92.23
- NBIX $84.23
- 52 Week High
- SNX $153.70
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- SNX 59.89
- NBIX 58.78
- Support Level
- SNX $148.92
- NBIX $140.56
- Resistance Level
- SNX $153.06
- NBIX $145.16
- Average True Range (ATR)
- SNX 2.10
- NBIX 3.65
- MACD
- SNX 0.12
- NBIX 0.26
- Stochastic Oscillator
- SNX 81.75
- NBIX 67.79
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.